Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety Study of Concurrent Chemoradiation Therapy to Treat Locally Advanced Cervical Cancer

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Previously untreated, histologically confirmed cervical cancer~* One of following histologic types Squamous carcinoma, adenocarcinoma, adenosquamous carcinoma~* Age: 20-75 years~* GOG performance status: 0-2~* Adequate organ function Bone marrow: WBC ≥ 3,000/mm3, ANC ≥ 1,500/mm3, Platelet ≥ 100X103/mm3, Hb ≥ 10.0 g/dl Kidney: Creatinine \< 1.25 × UNL, Liver : AST, ALT \< 3 × UNL, T- bilirubin \< 1.5 mg/ mm3~* Contraception during study treatment~* Informed consent~Exclusion Criteria:~* Previous chemotherapy or pelvic radiation therapy~* Hormone therapy within 4 weeks~* Concomitant malignancy within 5 years except cured basal cell carcinoma of skin~* Uncontrolled medical disease~* Pregnant or lactating woman~* Etc.

- Gender: FEMALE
- Minimum Age: 20 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- CCRT weekly carboplatin (Type: EXPERIMENTAL): Concurrent chemoradiation therapy with weekly carboplatin
- CCRT weekly cisplatin (Type: ACTIVE_COMPARATOR): Concurrent chemoradiation therapy with weekly cisplatin

Based on this trial design, predict the completion outcome and termination type (if applicable).